Literature DB >> 12196128

Examining the structure of the mature amyloid fibril.

O S Makin1, L C Serpell.   

Abstract

The pathogenesis of the group of diseases known collectively as the amyloidoses is characterized by the deposition of insoluble amyloid fibrils. These are straight, unbranching structures about 70-120 A (1 A=0.1 nm) in diameter and of indeterminate length formed by the self-assembly of a diverse group of normally soluble proteins. Knowledge of the structure of these fibrils is necessary for the understanding of their abnormal assembly and deposition, possibly leading to the rational design of therapeutic agents for their prevention or disaggregation. Structural elucidation is impeded by fibril insolubility and inability to crystallize, thus preventing the use of X-ray crystallography and solution NMR. CD, Fourier-transform infrared spectroscopy and light scattering have been used in the study of the mechanism of fibril formation. This review concentrates on the structural information about the final, mature fibril and in particular the complementary techniques of cryo-electron microscopy, solid-state NMR and X-ray fibre diffraction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196128     DOI: 10.1042/bst0300521

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  11 in total

1.  The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.

Authors:  Richard W McLaughlin; Janelle K De Stigter; Laura A Sikkink; Elizabeth M Baden; Marina Ramirez-Alvarado
Journal:  Protein Sci       Date:  2006-06-02       Impact factor: 6.725

2.  Amyloid fibril formation can proceed from different conformations of a partially unfolded protein.

Authors:  Martino Calamai; Fabrizio Chiti; Christopher M Dobson
Journal:  Biophys J       Date:  2005-09-16       Impact factor: 4.033

Review 3.  Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.

Authors:  Vladimir N Uversky; Alexander V Kabanov; Yuri L Lyubchenko
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

4.  Dehydration stability of amyloid fibrils studied by AFM.

Authors:  Gjertrud Maurstad; Marcus Prass; Louise C Serpell; Pawel Sikorski
Journal:  Eur Biophys J       Date:  2009-08-14       Impact factor: 1.733

5.  Detection of high-molecular-weight amyloid serum protein complexes using biological on-line tracer sedimentation.

Authors:  Jonathan S Kingsbury; Thomas M Laue; Susan F Chase; Lawreen H Connors
Journal:  Anal Biochem       Date:  2012-03-27       Impact factor: 3.365

6.  Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro.

Authors:  Silvia Vilasi; Rosalba Sarcina; Rosa Maritato; Antonella De Simone; Gaetano Irace; Ivana Sirangelo
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

Review 7.  Differential effects of glycation on protein aggregation and amyloid formation.

Authors:  Clara Iannuzzi; Gaetano Irace; Ivana Sirangelo
Journal:  Front Mol Biosci       Date:  2014-09-02

Review 8.  Measurement of amyloid formation by turbidity assay-seeing through the cloud.

Authors:  Ran Zhao; Masatomo So; Hendrik Maat; Nicholas J Ray; Fumio Arisaka; Yuji Goto; John A Carver; Damien Hall
Journal:  Biophys Rev       Date:  2016-11-23

9.  Biochemical and aggregation analysis of Bence Jones proteins from different light chain diseases.

Authors:  Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Amyloid       Date:  2008-03       Impact factor: 7.141

Review 10.  The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity.

Authors:  Clara Iannuzzi; Gaetano Irace; Ivana Sirangelo
Journal:  Molecules       Date:  2015-02-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.